Early in my fourth year of med school, when I was trying to decide what type of residency to apply for, I realized that I enjoyed the breadth of the scope of practice a family physician embraces. I tell my patients that I specialize in what they walk through the door with. As a family physician I have to be comfortable and competent at seeing nearly any patient for any problem and helping them access the care that they need for the problem they present asking for help with. In addition I have to try to recognize problems or health risks that they may not recognize, and have to find a way to let my patients accept what I feel is appropriate preventative care and disease management. I need to be familiar with a vast array of medications, from psyllium to pradaxa, and problems from PSVT to psychogenic cough.
I often am asked by patients if they should come see me or if they should just go directly to the specialist they feel is going to be able to definitively address their concern. I don’t mean to sound pompous here, but often patients are way off base in choosing the specialist best suited to their problem. Seeing a specialist in an arena of healthcare different from your problem has several risks. These include significant delay in receiving appropriate care, incurring the expense of extensive testing in their area of interest prior to reaching the specialist appropriate to your circumstances, overdiagnosis, and missing related or unrelated problems that a family physician may recognize but a sub-specialist may not notice. Let’s go through these in more detail:
- Delay in Receiving Appropriate Care: This can be the result of various causes. The one most concerning to me is when a patient makes a self-diagnosis and sees a specialist in that field. Often symptoms that seem related to one area expertise are caused by a disorder not apparent to the patient. Epigastric pain and nausea may be the result of heartburn and a gastroenterologist may be suited to evaluate and treat the pain. On the other hand it may be related to coronary ischemia and need urgent intervention. Seeing a gastroenterologist is not only not going to help, but may delay care, either because of a longer time to get an appointment for evaluation or because specialists often extensively evaluate issues in their area of concern prior to referral to another specialist. The time to have a trial of a medication for acid reflux and have an endoscopic exam of the esophagus and stomach may be detrimental to the care of a patient with coronary disease.
- Incurring Expensive Testing: When a patient sees a family physician they are likely evaluated for the most serious or most likely problems causing their symptoms. The list of potential concerns often extends across several areas of sub-specialty interest. By looking at the most serious and most likely issues first a family physician is more likely to avoid expensive tests for very unlikely problems. An example might be a patient with groin pain. If this patient sees a family doctor, they will probably be evaluated by history and physical exam for things like inguinal hernia, urologic causes like kidney stone and infection, hip pathology, in women ovarian-gynecologic issues including ectopic pregnancy, gastrointestinal causes and neurologic causes. If they see a urologist they are likely to have extensive evaluation for urologic problems, and may get a correct diagnosis of a kidney stone or UTI. If their problem very likely a gynecologic problem, they are still likely to have extensive evaluation for the urologic issues because no specialist wants to miss a diagnosis in their field of expertise no matter how low the likelihood may be. This holds true for most specialists. If you see a sub-specialist you are very likely to have an extensive evaluation for problems in their scope of practice whether or not they think you likely have a problem in their realm. A family physician is more likely to go through a process of looking for problems they consider important and likely, and put off extensive evaluation for very unlikely diagnoses. The cost savings of the latter approach can be huge.
- Overdiagnosis: I’ll be brief here, but if you have imaging like an MRI, CT scan, ultrasound or even many lab tests abnormalities are often noted that can lead to extensive testing which has its own risks, or diagnosis of a problem that does not now nor will ever bother you. The latter is called overdiagnosis. See a prior post on overdiagnosis for more information on this topic. Overdiagnosis may lead to medication side effects, risks of unnecessary procedures, and emotional distress.
- Missing related or unrelated Problems: A specialist while highly trained in their scope of practice may not be focused on related or unrelated important health care issues. If you see a cardiologist it is unlikely that they are going to recognize that you are due for a mammogram and urge you to get a preventative care visit for this and other preventative services you are due. If you see a dermatologist it is unlikely you will bring up your “Oh doctor, by the way I am having these odd numbness and weakness symptoms,” that may lead your family physician to consider a TIA and make interventions to prevent stroke. The list of similar situations is nearly endless.
I feel pretty strongly that the first point of care for most health concerns should be either your family physician or the emergency department for life threatening emergencies. The scope of practice of your family physician gives you the best chance of efficient, timely and effective care.
Yesterday the FDA approved the first cord blood product, to be marketed as Hemacord™ with indications for cord blood stem cell transplant procedures in patient with some types of blood malignancies like leukemia as well as some inherited metabolic and immune system disorders. I think this could be just the beginning of much more widespread use of cord blood products for therapy. Cord blood is the blood left in the umbilical cord and the placenta after childbirth. It is routinely discarded as biologic waste, although in recent years some patents with enough financial means and interest have been having a sample of their newborn infant’s cord blood saved at a cord blood bank, and some public blood banks have begun to collect and store cryopreserved cord blood for public use. The potential supply of cord blood for therapeutic use would seem to far outweigh the need, and I expect that if cord blood stem cells continue to be as promising as they appear to be, namely as effective as bone marrow or other stem cells for transplant, that their use will become commonplace.
to try to improve the estimation of a woman’s risk for having a trisomy-21, or Down’s syndrome pregnancy without actually obtaining fetal cells, but all they have really done is improve statistical prediction capability. Up to this point in order to tell if a woman is carrying a Down’s Syndrome baby required amniocentesis to obtain amniotic fluid at about 16-18 weeks gestation, or the arguably higher risk chorioamniotic villous sampling at 10-12 weeks gestation. Both of these tests ran low (estimated 1/350) but real risks of fetal injury and miscarriage. Now from a company named Sequenom™ comes a test on fetal cells obtained by a venous blood sample of the pregnant women’s blood as early as 10 weeks gestation that can do genetic screening for Down’s Syndrome without more invasive ways to obtain fetal cells. The initial study of 212 women showed a >99% accuracy rate. (1 false positive, 2 false negatives in 212 women tested).


